Literature DB >> 7743374

The efficacy of heparin and antithrombin III in fluid-resuscitated cecal ligation and puncture.

S Yang1, J G Hauptman.   

Abstract

Sepsis/septic shock and multiple organ failure are important causes of morbidity and mortality. Our objective was to study sepsis and organ failure in a fluid-resuscitated septic model. Males S-D rats were anesthetized with halothane, the jugular vein catheterized, and CLP performed. Each rat was maintained in a metabolism cage on continuous intravenous fluid (3 mL/rat). Urine rate and [creatinine]urine were measured daily. At day 5, serum creatinine with chemistry profile, complete blood count, clotting times, and wet lung/body weight ratios were also measured. Glomerular filtration rate (GFR) was measured according to the principle of endogenous creatinine clearance. GFR was correlated with the product of urine rate x [creatinine]urine (R = .79), so that product was used as a daily indicator of GFR. Urine output remained > or = normal during sepsis. Heparin and antithrombin III were tested in this model. The model was associated with 40% mortality, a 60% reduction in platelet count, liver damage, a 75% reduction in renal function, muscle damage, and a normal wet lung/body weight ratio. Treatment with heparin/antithrombin III ameliorated the decrease in GFR (p < .05) observed in the nontreated animals, prevented the septic-induced thrombocytopenia (p < .05), and improved survival (p = .05).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7743374     DOI: 10.1097/00024382-199412000-00008

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  4 in total

Review 1.  The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.

Authors:  Yan Li; Jun-Feng Sun; Xizhong Cui; Haresh Mani; Robert L Danner; Xuemei Li; Jun-Wu Su; Yvonne Fitz; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

2.  High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Shigekiyo Matsumoto; Takayuki Noguchi
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

Review 3.  Animal models of sepsis and sepsis-induced kidney injury.

Authors:  Kent Doi; Asada Leelahavanichkul; Peter S T Yuen; Robert A Star
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

4.  Heparanase mediates renal dysfunction during early sepsis in mice.

Authors:  Melissa I Lygizos; Yimu Yang; Christopher J Altmann; Kayo Okamura; Ana Andres Hernando; Mario J Perez; Lynelle P Smith; Daniel E Koyanagi; Aneta Gandjeva; Rhea Bhargava; Rubin M Tuder; Sarah Faubel; Eric P Schmidt
Journal:  Physiol Rep       Date:  2013-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.